Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The four new ESC Guidelines were presented for the first time during this session.
Helmut Baumgartner provided us with a brief summary of the disease then giving recommendations on the diagnosis and management, including medical,surgical, and interventional aspects, but also important practical points such as recommendations for exercise, pregnacy, and even insurance.
Wiliam Wijns and Philip Kohl gave recommendations for the diagnosis and performance of revesculariation, either by surgery or intervention, according to anatomy and clinical presentation. They also provided guidance on medical therapy, especially antithrombotic therapy, which accompanies revascularisation, and organisation of PCI centers and patient information.
John Camm reviewed the new aspects of medical therapy, whether there are anti thrombotic agents or anti arrhythmic drugs, and ablation either via interventional techniques or surgery.
Kenneth Dickstein highlighted the management of patients with left ventricular dysfunction but few symptoms, those with atrial fibrillation, and finally patients who already have stimulation in place. More comprehensive presentations of these new guidelines will be given during the congress in specific sessions for each of them.
New this year are the "Meet with the Task force sessions", held on Monday and Tuesday where you can ask the Task Force chairpersons all the questions you may have on the topic.
© 2017 European Society of Cardiology. All rights reserved